Related references
Note: Only part of the references are listed.C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection
Maggie Yell et al.
TRANSPLANTATION (2015)
Prevalence, Incidence and Risk Factors for Donor-Specific Anti-HLA Antibodies in Maintenance Liver Transplant Patients
A. Del Bello et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Antibody-Mediated Rejection as a Contributor to Previously Unexplained Early Liver Allograft Loss
Jacqueline G. O'Leary et al.
LIVER TRANSPLANTATION (2014)
Acute Liver Allograft Antibody-Mediated Rejection: An Inter-Institutional Study of Significant Histopathological Features
Jacqueline G. O'Leary et al.
LIVER TRANSPLANTATION (2014)
Determinants of C1q Binding in the Single Antigen Bead Assay
Stefan Schaub et al.
TRANSPLANTATION (2014)
De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients
H. Kaneku et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation
Jacqueline G. O'Leary et al.
LIVER TRANSPLANTATION (2013)
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Alexandre Loupy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts
Matthew J. Everly et al.
TRANSPLANTATION (2013)
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Prevalence, Course and Impact of HLA Donor-Specific Antibodies in Liver Transplantation in the First Year
T. Taner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation
F. Paterno et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation
Speranta Iacob et al.
LIVER INTERNATIONAL (2012)
Implications of a positive crossmatch in liver transplantation: A 20-year review
Richard Ruiz et al.
LIVER TRANSPLANTATION (2012)
Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation
Hugo Kaneku et al.
LIVER TRANSPLANTATION (2012)
Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts
Aya Miyagawa-Hayashino et al.
LIVER TRANSPLANTATION (2012)
Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale
Thomas Fehr et al.
TRANSPLANT INTERNATIONAL (2012)
The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation
A. I. Musat et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients
Clifford Chin et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Liver Allograft Antibody-Mediated Rejection With Demonstration of Sinusoidal C4d Staining and Circulating Donor-Specific Antibodies
Tomasz Kozlowski et al.
LIVER TRANSPLANTATION (2011)
Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation
Nassim Kamar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility
Marcela Castillo-Rama et al.
LIVER TRANSPLANTATION (2008)
Predicting kidney graft failure by HLA antibodies: a prospective trial
PI Terasaki et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Share Paper
